Viridian Therapeutic (VRDN) PT Lowered to $37 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts VRDN Hot Sheet
Price: $21.99 -3.89%
Rating Summary:
16 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 3
Rating Summary:
16 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 3
Join SI Premium – FREE
H.C. Wainwright analyst Douglas Tsao lowered the price target on Viridian Therapeutic (NASDAQ: VRDN) to $37.00 (from $40.00) while maintaining a Buy rating.
You May Also Be Interested In
- Nomura/Instinet Downgrades Korea Electric Power Corp. (015760:KS) (KEP) to Neutral
- Fast Retailing Co Ltd. (9983:JP) (FRCOY) PT Raised to JPY77,000 at Nomura/Instinet
- JPMorgan Downgrades HomeCo Daily Needs REIT (HDN:AU) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
